Food for thought... increased attentionTry running a Youtube search for Oncolytics Biotech... there are plenty of videos dating back to the dark ages of Brad Thomson, spewing all kinds of nonsense about seamless Phase III trials... pure BS in retrospect.
But those videos and Ellis Reports only have a few hundred views at best...
Roll on the latest interview with Matt a couple of weeks ago, and views are already numbering 3.7k... ten times those of previous years.
Hopefully this signals a shift of focus BACK to ONCY. Today's news was most welcome, but do remember that in one of those interviews from 2017, Matt is talking of having received Fast Track approval for mBC, and we know how long it's taken to get to running a Phase III from that...
If history repeats, then tomorrow may start up, finish slightly down, and then continue dropping until after the poster presentations, only to drop back to where the run started. I hope I'm wrong this time, but long termers have seen this time and time again.
GLTA